$VXRT SEC Filings

Filed On	Filing
20 Oct 2026	Form 4: Bono Raquel C., Director Received 78,800 shares as a grant or award · Granted 157,400 Stock Option (right to buy)
20 Oct 2026	Form 3: Bono Raquel C., Director No securities owned
19 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure Board-certified surgeon and former Director of the Defense Health Agency brings extensive leadership, public health and governance experience
14 Sep 2026	8-K: Other Events On September 3, 2026, the Board of Directors (the “Board”) of Vaxart, Inc. (the “Company”), approved a Director Resignation Policy that requires a director, following certification of the stockholder vote from the meeting at which the el...
25 Aug 2026	8-K: Other Events
06 Aug 2026	FORM 10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition
28 Jul 2026	8-K: Other Events
20 Jul 2026	Form 4: Finney Kevin, Director Received 39,400 shares as a grant or award · Granted 78,700 Stock Options (right to buy)
17 Jul 2026	Form 4: Breitmeyer James B, Director Received 8,315 shares as a grant or award · Granted 16,610 Stock Options (right to buy)
17 Jul 2026	Form 4: Heron Elaine J, Director Received 39,400 shares as a grant or award · Granted 78,700 Stock Options (right to buy)
17 Jul 2026	Form 4: Watson W. Mark, Director Received 39,400 shares as a grant or award · Granted 78,700 Stock Options (right to buy)
17 Jul 2026	Form 4: Wheadon David E., Director Received 39,400 shares as a grant or award · Granted 78,700 Stock Options (right to buy)
17 Jul 2026	8-K: Submission of Matters to a Vote of Security Holders; Regulation FD Disclosure
07 Jul 2026	8-K: Other Events
06 Jul 2026	DEFINITIVE ADDITIONAL MATERIALS
02 Jul 2026	DEFINITIVE ADDITIONAL MATERIALS
02 Jul 2026	DFAN14A
02 Jul 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
01 Jul 2026	DEFINITIVE ADDITIONAL MATERIALS

Comments